OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
December 01, 2016
The House-approved 21st Century Cures legislation supports initiatives for medical research, drug development, and faster approvals, but comes up short on actual appropriations.
November 18, 2016
Biopharma proponents argue for FDA resources, Cures legislation, and science-based drug regulation.
November 09, 2016
What’s ahead for the healthcare and pharmaceutical industries?
November 02, 2016
Reliable, high-quality products require innovative analytics and production.
The biosimilar pathway permits licensure based on less than full clinical data.
October 24, 2016
FDA’s new Office of Tissues and Advanced Therapies will oversee a growing range of cellular and genetic products.